STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance Vision
Go back to STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance Vision| Staar Surgical Co (NASDAQ: STAA) | Delayed: 25.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.17 | 52 Week High | $10.95 | |||
| Open | $25.17 | 52 Week Low | $4.98 | |||
| Day High | $25.17 | P/E | N/A | |||
| Day Low | $25.17 | EPS | $-0.01 | |||
| Volume | 1,178 | |||||



